Latest Articles about VRTX

Vertex Loss Lower, Kalydeco Outlook Up - Analyst Blog

Zacks Equity Research — Wed, 01 May 2013 16:49:18 Z

Vertex Pharmaceuticals Inc. ( VRTX ) posted a loss of 12 cents per share (including stock-based compensation expense) in the first quarter of 2013, well below the year-ago earnings of 41

Benzinga Market Primer: Wednesday, May 1

Matthew Kanterman — Wed, 01 May 2013 14:37:37 Z

Futures Higher Ahead of Key Economic Data, Earnings U.S. equity futures rose in early pre-market trade ahead of key earnings and economic data. The FOMC rate decision and policy statement is due

After-Hours Earnings Report for April 30, 2013 : EQR, VRTX, AVB, BXP, FISV, OKE, VRSK, AUY, FMC, WU, OKS, TRMB

NASDAQ.com News — Tue, 30 Apr 2013 22:00:04 Z

The following companies are expected to report earnings after hours on 04/30/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Equity Residential ( EQR ) is

Benzinga Market Primer: Tuesday, April 30

Matthew Kanterman — Tue, 30 Apr 2013 14:38:40 Z

Futures Flat on Mixed Economic Data U.S. equity futures traded little changed in early pre-market trade following mixed global economic data. Mixed data out of Japan was followed by a flood of

Merck - BMY in HCV Deal - Analyst Blog

Zacks Equity Research — Wed, 24 Apr 2013 02:09:40 Z

Merck & Co. Inc. ( MRK ) recently joined forces with Bristol-Myers Squibb (BMY) to conduct a phase II study with their hepatitis C virus (HCV) candidates. The study will evaluate

FDA Approves Novartis' Simbrinza - Analyst Blog

Zacks Equity Research — Tue, 23 Apr 2013 02:12:49 Z

Novartis ( NVS ) recently announced that the US Food and Drug Administration (FDA) has approved Simbrinza Suspension for the reduction of elevated intraocular pressure (IOP) in patients

Merck In-Licenses from Xenon - Analyst Blog

Zacks Equity Research — Tue, 23 Apr 2013 02:11:06 Z

Merck & Co. Inc. ( MRK ) recently announced the in-licensing of Xenon Pharmaceuticals Inc.'s small molecule compounds for a novel target to treat cardiovascular disease. Merck and

Market Close Report: NASDAQ Composite index closes at 3,233.55 up 27.49 points

NASDAQ.com News — Tue, 23 Apr 2013 00:45:13 Z

Monday's session closes with the NASDAQ Composite Index at 3,233.55. The total shares traded for the NASDAQ was over 1.6 billion. Advancers stocks led declining by 1.08 to 1 ratio. There were

Market Close Report: NASDAQ Composite index closes at 3,206.06 up 39.70 points

NASDAQ.com News — Sat, 20 Apr 2013 00:45:16 Z

Friday's session closes with the NASDAQ Composite Index at 3,206.06. The total shares traded for the NASDAQ was over 1.68 billion. Advancers stocks led declining by 2.11 to 1 ratio. There were

PSTI Plans to Start Phase I Study - Analyst Blog

Zacks Equity Research — Sat, 20 Apr 2013 00:11:14 Z

Pluristem Therapeutics Inc. ( PSTI ) recently announced its intention to commence a phase I study that will evaluate the safety and efficacy of the local administration of PLacental

BMY, Santaris Pharma Team Up - Analyst Blog

Zacks Equity Research — Sat, 20 Apr 2013 00:10:30 Z

Bristol-Myers Squibb Co. ( BMY ) recently entered into a strategic alliance with privately-held biopharmaceutical company Santaris Pharma A/S to discover and develop medicines on a global

Vertex CF Candidate Impresses - Analyst Blog

Zacks Equity Research — Fri, 19 Apr 2013 23:40:01 Z

Vertex Pharmaceuticals Incorporated ( VRTX ) received a huge boost with the company reporting impressive phase II data on its cystic fibrosis (CF) candidate, VX-661. The randomized,

Mid-Day Market Update: Celanese Jumps On Upbeat Results, Rambus Declines

Jake L'Ecuyer — Fri, 19 Apr 2013 21:16:28 Z

Midway through trading Friday, the Dow traded down 0.08 percent to 14,525.77 while the NASDAQ gained 1.19 percent to 3,204.18. The S&P also rose, gaining 0.72 percent to 1,552.66.

Mid-Morning Market Update: Markets Mixed, General Electric Q1 Profit Surges 16%

Jake L'Ecuyer — Fri, 19 Apr 2013 18:02:53 Z

Following the market opening Friday, the Dow traded down 0.40 percent to 14,478.60 while the NASDAQ gained 0.21 percent to 3,172.88. The S&P also rose, gaining 0.16 percent to 1,544.10.

Pre-Market Most Active for Apr 19, 2013 : DELL, GE, VOD, QQQ, TOT, MSFT, BAC, VRTX, SAP, NOK, BIOS, DEO

NASDAQ.com News — Fri, 19 Apr 2013 16:39:55 Z

The NASDAQ 100 Pre-Market Indicator is up 16.35 to 2,758.3. The total Pre-Market volume is currently 12,552,022 shares traded. The following are the most active stocks for the pre-market